{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-093996","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.414582+00:00","generated_at":"2026-05-18T09:27:24.646448+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Xenon CFO Sherry Aulin resigns; CEO Ian Mortimer appointed interim CFO","bullets":["Sherry Aulin resigned as CFO, effective June 30, 2025.","Ian Mortimer (President & CEO) appointed interim CFO effective June 30, 2025, serving as principal financial and accounting officer.","No change to Mortimer's compensation in connection with the appointment.","Mortimer's background previously disclosed in the April 24, 2025 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-093996","json":"https://secwatch.observer/filing/0000950170-25-093996.json","markdown":"https://secwatch.observer/filing/0000950170-25-093996.md","text":"https://secwatch.observer/filing/0000950170-25-093996.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025093996/0000950170-25-093996-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025093996/xene-20250630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:27:24.646448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}